Susan Alesina - Aug 8, 2022 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Director
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Aug 8, 2022
Transactions value $
$0
Form type
4
Date filed
8/10/2022, 05:57 PM
Next filing
Mar 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALBO Stock Options (Right to buy) Award $0 +16K $0.00 16K Aug 8, 2022 Common Stock 16K $25.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest in equal annual installments over three years from August 8, 2022 (but, in any case, to be fully vested on the day prior to the annual meeting for the third fiscal year that begins following the date of grant), subject to the director's continued service on the issuer's board of directors on the vesting date.